A case of acute pancreatitis induced by telaprevir in the anti-HCV treatment with peginterferon and ribavirin

Misako Matsushita, Hirotoshi Ebinuma, Seiichirou Fukuhara, Kazushi Minami, Kazuhiro Minami, Nobuhiro Nakamoto, Shinsuke Funakoshi, Takanori Kanai, Hidetsugu Saito, Toshifumi Hibi

Research output: Contribution to journalArticlepeer-review


A 61-years-old man started the combination treatment with telaprevir, peginterferon-alfa 2b, and ribavirin against chronic hepatitis C after the cure of hepatocellular carcinoma. Telaprevir was reduced to 1500 mgday due to renal dysfunction but the serum HCV-RNA was disappeared on the 15th day. On the 18th day, he visited our hospital with severe epigastralgia and a high fever. He was diagnosed acute pancreatitis by elevation of his serum amylase (2905 IUL) and diffuse swelling of pancreas. We suspected the drug-induced pancreatitis and stopped telaprevir. Although peginterferon and ribavirin were continued for the treating acute pancreatitis, his HCV-RNA became positive again. Therefore we restarted telaprevir with plenty of informed consent after recovery of the pancreatitis. On the 10th day after the resume of telaprevir, the recurrence of the pancreatitis occurred and we stopped any anti-HCV treatment. These twice pancreatitis were immediately improved by the suspension of telaprevir and the administration of antibiotics and gabexate mesilate. We here report this case of telaprevir induced acute pancreatitis confirmed by the re-administration of telaprevir.

Original languageEnglish
Pages (from-to)340-346
Number of pages7
JournalActa Hepatologica Japonica
Issue number5
Publication statusPublished - 2013 May 30


  • Challenge test
  • Chronic hepatitis C
  • Drug-induced pancreatitis
  • Telaprevir
  • Triple therapy

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'A case of acute pancreatitis induced by telaprevir in the anti-HCV treatment with peginterferon and ribavirin'. Together they form a unique fingerprint.

Cite this